IGHE and atopic asthma: Syk et al. highlights the possibility of IgE reduction with common asthma control drugs, which is confirmed in patients with persistent atopic asthma with annual optimization of ICS and LTRA treatment, resulting in a significant decrease in total IgE correlating with a reduction in FENO and an improvement in asthma control and quality of life [66].